Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
103.138,03
-0,95%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Danaher Corporation (DHR) Danaher Corporation (DHR) Notizie

DHR

Danaher (DHR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:DHR
DataOraFonteTitoloSimboloCompagnia
15/01/202514:30PR Newswire (US)Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease ResearchNYSE:DHRDanaher Corporation
13/01/202522:22Edgar (US Regulatory)Form 8-K - Current reportNYSE:DHRDanaher Corporation
13/01/202522:15PR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
09/01/202522:15PR Newswire (US)Danaher Announces Investment Partnership in Innovaccer Inc.NYSE:DHRDanaher Corporation
06/01/202522:15PR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
02/01/202522:05PR Newswire (US)Danaher Schedules Fourth Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
19/12/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DHRDanaher Corporation
10/12/202422:15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
26/11/202423:00PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
26/11/202422:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DHRDanaher Corporation
08/11/202414:23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:DHRDanaher Corporation
22/10/202412:00PR Newswire (US)Danaher Reports Third Quarter 2024 ResultsNYSE:DHRDanaher Corporation
27/09/202414:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:DHRDanaher Corporation
19/09/202422:30PR Newswire (US)Danaher Schedules Third Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
17/09/202414:30PR Newswire (US)Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term PartnershipNYSE:DHRDanaher Corporation
04/09/202422:30PR Newswire (US)Danaher Confirms Third Quarter and Full Year 2024 GuidanceNYSE:DHRDanaher Corporation
26/08/202423:30PR Newswire (US)Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.NYSE:DHRDanaher Corporation
30/07/202413:30GlobeNewswire Inc.Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s DiseaseNYSE:DHRDanaher Corporation
25/07/202415:00PR Newswire (US)Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation CelebrationNYSE:DHRDanaher Corporation
23/07/202412:00PR Newswire (US)Danaher Reports Second Quarter 2024 ResultsNYSE:DHRDanaher Corporation
17/07/202413:30PR Newswire (US)Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine DevelopmentNYSE:DHRDanaher Corporation
16/07/202413:30PR Newswire (US)Danaher Releases 2024 Sustainability ReportNYSE:DHRDanaher Corporation
11/07/202413:30PR Newswire (US)Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug ScreeningNYSE:DHRDanaher Corporation
09/07/202409:00PR Newswire (US)Beckman Coulter Introduces New Integrated Chemistry and Immunoassay AnalyzerNYSE:DHRDanaher Corporation
24/06/202422:30PR Newswire (US)Danaher Schedules Second Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
19/06/202413:30PR Newswire (US)Danaher appoints Julie Sawyer Montgomery to Executive Vice President for DiagnosticsNYSE:DHRDanaher Corporation
05/06/202413:00PR Newswire (US)Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence OfficerNYSE:DHRDanaher Corporation
09/05/202413:00PR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
07/05/202422:45PR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
03/05/202415:06PR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:DHR

La tua Cronologia

USOTC
ELRA
Elray Resources (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network